Philip M Pead

CIK 1227485 · President and CEO · last filed 2022-10-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$20.17M

Companies

Total Filings

Lifetime Open-Market Net

$2.40M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

PRGS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. — 8 joint filings, latest 2012-03-27

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Change Healthcare Inc. (CHNGU) Delisted	Director	102,642	$73.71	$7.57M	$0	5	2022-04-27
PRGS	President and CEO	437,799	$46.06	$20.17M	$1.01M	20	2017-04-04
Veradigm Inc. (MDRX) Delisted	Chairman of the Board	294,312	$6.81	$2.00M	$0	7	2012-03-27
Emdeon Inc. (EM) Delisted	Director	36,880	$1.20	$44.1K	$387.5K	5	2011-08-26
ECLIPSYS CORP (ECLP) Delisted	CEO	136,179	—	—	$995.6K	5	2010-03-17

Recent Filings · Page 2 of 5

45 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-01-28	PRGS	Grant (A)	—	$0	EDGAR
2016-01-20	PRGS	Grant (A)	—	$0	EDGAR
2015-10-05	PRGS	Mixed	+59,841	-$1.14M	EDGAR
2015-04-03	PRGS	Mixed	+61,806	-$1.06M	EDGAR
2015-03-04	PRGS	Grant (A)	—	$0	EDGAR
2015-01-21	PRGS	Sell (S)	+20,000	$498.4K	EDGAR
2015-01-20	PRGS	Grant (A)	+20,000	$498.4K	EDGAR
2014-10-03	PRGS	Mixed	+58,961	-$1.01M	EDGAR
2014-01-15	PRGS	Grant (A)	—	$0	EDGAR
2014-01-09	PRGS	Grant (A)	—	$0	EDGAR

Showing 11–20 of 45

Prev Page 2 of 5 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.